These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 19565103

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The discriminative power of the EuroQol visual analog scale is sensitive to survey language in Singapore.
    Luo N, Cang SQ, Quah HM, How CH, Tay EG.
    Health Qual Life Outcomes; 2012 Mar 20; 10():32. PubMed ID: 22429829
    [Abstract] [Full Text] [Related]

  • 3. Convergent validation of EQ-5D-5L in patients with Parkinson's disease.
    Alvarado-Bolaños A, Cervantes-Arriaga A, Rodríguez-Violante M, Llorens-Arenas R, Calderón-Fajardo H, Millán-Cepeda R, Leal-Ortega R, Estrada-Bellmann I, Zuñiga-Ramírez C.
    J Neurol Sci; 2015 Nov 15; 358(1-2):53-7. PubMed ID: 26276513
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Validity and reliability of the Chinese (Singapore) version of the Parkinson's Disease Questionnaire (PDQ-39).
    Luo N, Tan LC, Li SC, Soh LK, Thumboo J.
    Qual Life Res; 2005 Feb 15; 14(1):273-9. PubMed ID: 15789961
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Validity and reliability of the EQ-5D self-report questionnaire in English-speaking Asian patients with rheumatic diseases in Singapore.
    Luo N, Chew LH, Fong KY, Koh DR, Ng SC, Yoon KH, Vasoo S, Li SC, Thumboo J.
    Qual Life Res; 2003 Feb 15; 12(1):87-92. PubMed ID: 12625521
    [Abstract] [Full Text] [Related]

  • 8. Validity and reliability of the PDQ-39 and the PDQ-8 in English-speaking Parkinson's disease patients in Singapore.
    Tan LC, Luo N, Nazri M, Li SC, Thumboo J.
    Parkinsonism Relat Disord; 2004 Dec 15; 10(8):493-9. PubMed ID: 15542010
    [Abstract] [Full Text] [Related]

  • 9. Real-world assessment of the impact of "OFF" episodes on health-related quality of life among patients with Parkinson's disease in the United States.
    Thach A, Jones E, Pappert E, Pike J, Wright J, Gillespie A.
    BMC Neurol; 2021 Jan 30; 21(1):46. PubMed ID: 33516182
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mapping of the PDQ-39 to EQ-5D scores in patients with Parkinson's disease.
    Young MK, Ng SK, Mellick G, Scuffham PA.
    Qual Life Res; 2013 Jun 30; 22(5):1065-72. PubMed ID: 22782690
    [Abstract] [Full Text] [Related]

  • 13. Responsiveness of the EQ-5D and 8-item Parkinson's Disease Questionnaire (PDQ-8) in a 4-year follow-up study.
    Luo N, Ng WY, Lau PN, Au WL, Tan LC.
    Qual Life Res; 2010 May 30; 19(4):565-9. PubMed ID: 20204708
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD).
    Yang F, Lau T, Lee E, Vathsala A, Chia KS, Luo N.
    Eur J Health Econ; 2015 Dec 30; 16(9):1019-26. PubMed ID: 25519850
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Converting Parkinson-Specific Scores into Health State Utilities to Assess Cost-Utility Analysis.
    Chen G, Garcia-Gordillo MA, Collado-Mateo D, Del Pozo-Cruz B, Adsuar JC, Cordero-Ferrera JM, Abellán-Perpiñán JM, Sánchez-Martínez FI.
    Patient; 2018 Dec 30; 11(6):665-675. PubMed ID: 29876865
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Construct validity and reliability of EQ-5D-3L for stroke survivors in a lower middle income setting.
    Mahesh PKB, Gunathunga MW, Jayasinghe S, Arnold SM, Senanayake S, Senanayake C, De Silva LSD, Kularatna S.
    Ceylon Med J; 2019 Jun 30; 64(2):52-58. PubMed ID: 31455067
    [Abstract] [Full Text] [Related]

  • 19. The English and Chinese versions of the five-level EuroQoL Group's five-dimension questionnaire (EQ-5D) were valid and reliable and provided comparable scores in Asian breast cancer patients.
    Lee CF, Ng R, Luo N, Wong NS, Yap YS, Lo SK, Chia WK, Yee A, Krishna L, Wong C, Goh C, Cheung YB.
    Support Care Cancer; 2013 Jan 30; 21(1):201-9. PubMed ID: 22669608
    [Abstract] [Full Text] [Related]

  • 20. Population norms for the EQ-5D index scores using Singapore preference weights.
    Abdin E, Subramaniam M, Vaingankar JA, Luo N, Chong SA.
    Qual Life Res; 2015 Jun 30; 24(6):1545-53. PubMed ID: 25394893
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.